Quantcast

Latest ovarian cancer Stories

2014-06-17 16:25:41

NEW YORK, June 17, 2014 /PRNewswire/ -- According to GLOBOCAN 2012, breast cancer was the second most commonly diagnosed form of cancer in 2012 with 1.7 million new cases, and accounting for nearly 12% of all new cancer cases. Since the 2008 estimates, breast cancer incidence has increased by more than 20% while mortality has increased by 14%. With approximately 522,000 deaths in 2012, breast cancer is now the most common cause of cancer death among women. Furthermore, it is...

2014-06-17 08:28:31

Companies expect to commence first-in-human studies of Trx-1 in ovarian cancer in 1H15 BOSTON, June 17, 2014 /PRNewswire/ -- Australian oncology drug development company Novogen Limited [ASX:NRT; NASDAQ:NVGN] and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity. Based on the...

2014-06-13 08:23:53

Common stock to begin trading under "CASI" on June 16, 2014 ROCKVILLE, Md., June 13, 2014 /PRNewswire/ -- EntreMed, Inc. (Nasdaq: ENMD), a clinical-stage biopharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that at its annual meeting of stockholders held on June 12, 2014, stockholders voted in favor of changing the company's corporate name to CASI Pharmaceuticals, Inc. The name change will occur on June 16, 2014 with the...

2014-06-11 08:31:25

LONDON, June 11, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Cancer Diagnostic Testing World Marketshttp://www.reportbuyer.com/pharma_healthcare/diagnostics/cancer_diagnostic_testing_world_markets.html Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment. The National Cancer Institute estimates that about ten million Americans have or have had some form of cancer. Overall costs...

2014-06-11 08:29:54

All 9 Out Of 9 Patients Who Have Reached 4 Injections Are Showing Tumor Cell Death, Tumor Shrinkage And/Or Stabilization Of Disease BETHESDA, Md., June 11, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that, in the ongoing Phase I/II clinical trial of DCVax-Direct for all types of inoperable solid tumors, all 9 out of 9 patients who have...

2014-06-10 16:29:08

Kelly Ripa Stars in Public Service Announcements for "QVC Presents Super Saturday LIVE," Benefitting Ovarian Cancer Research Fund WEST CHESTER, Pa., June 10, 2014 /PRNewswire/ -- Kelly Ripa is shopping to save lives as she fills up her bag with designer deals that will contribute to the cure for ovarian cancer. Ripa, one of the most renowned hosts in morning television, will appear in both the print and television public service announcements promoting "QVC Presents Super Saturday...

2014-06-09 23:09:24

In CHAMPS Oncology's most recent blog post, Cancer Registry on the TODAY Show, Rhonda Spoden shares her thoughts on the topic. Cleveland, OH (PRWEB) June 09, 2014 In CHAMPS Oncology's most recent blog post, Cancer Registry on the TODAY Show, Rhonda Spoden shares her thoughts on the topic. It isn’t often the cancer registry makes national headlines, and (as much as she loves and respects the profession) Spoden never expected to hear about the cancer registry on the TODAY Show....

2014-06-09 12:31:07

TSX Venture: QPT EDMONTON, June 9, 2014 /PRNewswire/ - Quest PharmaTech Inc. (TSX-V: QPT) ("Quest" or the "Company"), a pharmaceutical company developing and commercializing products for the treatment of cancer, reports today that patient enrollment has been completed in the Company's Phase IIb clinical trial of its lead immunotherapy product candidate Oregovomab for the treatment of Ovarian Cancer. "I am pleased that we have reached this important milestone in our clinical program"...

2014-06-05 08:28:09

Median Overall Survival was 8 Years Longer for Women who were Treated with Therapies Consistent with Caris Molecular Intelligence(TM) Tumor Profiling Prediction and was 2 ½ years Longer after Recurrence IRVING, Texas, June 5, 2014 /PRNewswire/ -- Caris Life Sciences® and investigators from Inova Fairfax Hospital presented the first clinical outcomes data presentation from the Caris Registry(TM) at the 50(th) annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago,...

2014-06-03 23:09:20

Inhibiting enzymes that cause changes in gene expression could decrease chemotherapy resistance in ovarian cancer patients, researchers at Georgia State University and the University of Georgia say. Atlanta, Georgia (PRWEB) June 03, 2014 Inhibiting enzymes that cause changes in gene expression could decrease chemotherapy resistance in ovarian cancer patients, researchers at Georgia State University and the University of Georgia say. Dr. Susanna Greer, associate professor of biology, and...


Latest ovarian cancer Reference Libraries

Ovaries
2013-03-05 14:55:04

The ovaries are the two reproductive female organs where the eggs are produced. These are parallel to the testes in men. Formation and Orientation Each ovary is the size of an almond and is located on one side of the pelvis before the ureter and internal iliac artery but after the external iliac artery. They are attached to either side of the uterus. They are connected and release eggs to fallopian tubes, though not attached, monthly during the menstrual cycle. They also produce...

More Articles (1 articles) »
Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related